Published Jul 06, 2026

How high-throughput and adaptive manual screening compare when the objective is to identify and confirm the thermodynamically stable form of an API.

Real Question in Stable Form Screening

Underlying the comparison is a distinction worth stating plainly: throughput and reliability are different axes. Throughput describes how many conditions a platform can run at once. Reliability describes whether the forms it produces can be isolated, characterized, and confirmed. A screen can be fully automated yet still yield hits that cannot be advanced, either because the material formed is too small to characterize or because the crystallization event was never observed.

The Two Screening Approaches

High-throughput screening (HTS) uses automated, parallel, microplate-based workflows to run hundreds to thousands of crystallization conditions at once. Its defining strength is breadth: because the polymorphic landscape of an API cannot yet be reliably predicted, running many trials raises the chance of discovering forms, which makes HTS valuable for broad and fast exploration of the polymorphic landscape and IP-focused screening. Rational, in-silico-guided design can also direct which conditions are screened, improving the efficiency of large campaigns.

Manual screening uses direct, individual-vessel crystallization built on two design principles. The first is rational upfront design: the initial set of 50 to 100 experiments is selected based on the compound’s measured properties (solubility, pKa, ionization potential, chemical stability) across the full range of crystallization facilitating mechanisms, including cooling, evaporation, anti-solvent addition, slurry conversion, vapor and liquid diffusion, and grinding. The second is adaptive refinement: results from each round inform the design of the next, with direct optical inspection between steps guiding the screen toward the conditions most likely to yield relevant forms. Each condition is run at milligram scale, providing enough solidity to characterize the forms using XRPD, DSC, TGA, DVS, HPLC, and spectroscopy such as Raman, IR, and solution NMR, supported by polarized light microscopy and particle size analysis.

Two points are worth separating, because they are often conflated. Rational upfront design is not exclusive to manual screening; a well-designed HTS plate can also be populated from a compound's properties. What the manual format uniquely enables is the adaptive half, observing crystallization events directly and adjusting in response, which depends on having enough material and direct observation of each experiment. That distinction is the basis for the comparison that follows.

Comparing the Two Approaches

The table sets the two approaches against the dimensions that most directly determine stable-form outcomes. HTS retains its genuine strengths in breadth and speed; manual screening retains its advantages in observation, control, and better characterization. The intent is an honest engineering comparison.

HTS leads on the count-based dimensions it was built for. Manual screening leads to the dimensions that determine whether a hit can be trusted: enough material to characterize, direct observation of what has formed, and the ability to act on it. Why those advantages matter for stable-form identification is the subject of the next section.

Why This Matters for Stable-Form Identification

The relevance of observation and adaptability follows from how stable forms tend to appear. Crystallization from solution often produces a less stable phase first, which then transforms toward the more stable form. The generality of this sequence, historically framed as Ostwald's rule of stages, continues to be examined and refined in the crystallization literature, but the practical consequence is well established: the most stable polymorph is frequently the end point of a transformation rather than the first solid to appear.¹

This is why solvent-mediated, or slurry, transformation is a standard route to reaching and confirming the stable form. The metastable phase dissolves and the more stable phase grows in its place, with the transformation rate depending on factors such as solubility, temperature, and agitation.² Catching that transformation, and giving it the conditions and time to occur, is exactly what direct observation and adaptive follow-up enable. A fixed, sealed, mass-limited run can miss a conversion that happens after the plate is read, or register a hit and leave too little solid to confirm what it was. Because the plate cannot be redesigned mid-run, it also cannot follow the trail when a first-round result opens.

Adaptive manual screening is organized around these moments. For promising hits, including anhydrates and hydrates, the work continues into re-preparation, thermodynamic relationship studies, water activity studies for hydrates, stability assessment, and kinetic solubility measurement. The objective is not only to observe a form, but to produce it at a scale and under conditions that allow a team to demonstrate it is the stable one. For this specific objective, and at typical screening scale, which is where manual screening is most compelling. Where the objective is comprehensive form-space coverage or late-stage IP protection, the breadth of high-throughput screening is the better fit, and a high-throughput or hybrid approach has a clear place.

Matching the Strategy to Your Objective

Screening strategy should follow the development objective rather than a default preference for either method. The decision guide below traces common objectives to the approach each one tends to favor.

The practical takeaway is to scope the screen to the question being asked. For confirming a stable form, the most useful measure is not how many experiments a vendor can run, but how dependable and characterizable the result of each one will be.

How Crystal Pharmatech Can Help

Crystal Pharmatech's solid form screening is built on the adaptive approach described here. Screens are designed from each compound's physicochemical profile, executed across the full range of crystallization techniques, and refined as results come in, with hits characterized using a complete analytical suite spanning XRPD, DSC, TGA, DVS, and spectroscopy. For projects that require comprehensive form-space coverage or late-stage IP protection, the same team scales the screen accordingly and can discuss high-throughput approaches on a case-by-case basis.

With more than 2,000 drug molecules studied and over 1,000 clients served across discovery, development, and commercialization, the solid-state team brings deep practical experience to stable-form identification, crystallization development, and downstream formulation readiness. To discuss the right screening strategy for your compound, contact our solid-state team for a technical consultation.

Related Resources

• API Form and Solid-State Research: evaluation of the solid form landscape to identify and develop the optimal crystal form.

• Crystallization Development Services: scalable crystallization process development that consistently delivers the target crystal form.

• Preformulation Studies: characterization of API properties to support PK/PD and GLP toxicology programs.

Frequently Asked Questions

How many experiments are needed to identify a stable crystalline form?

For many compounds, an screen of 50 to 100 designed experiments with hit characterization is sufficient to identify the thermodynamically stable polymorph. Projects aimed at maximizing metastable forms for IP can expand to several hundred experiments.

Is high-throughput screening better than manual screening?

Neither is universally better; they suit different objectives. High-throughput screening excels at broad form-space surveys and IP-focused work where breadth is the goal. For confident identification of the stable form at typical scale, manual screening offers better data quality, characterizability, and process control.

Why can sample mass be a limitation in HTS?

Microplate-based screening can generate sub-milligram quantities per condition, which may fall below the amount needed for reliable characterization by XRPD, DSC, and TGA. Confirming a new phase requires preparing it in sufficient quantity, so a hit may not be advanceable until it is reproduced at larger scale.

Why does observation matter when screening for the stable form?

Stable forms often appear through a sequence in which a metastable phase transforms into the more stable one. Observing these transformations and giving them the conditions and time to occur through approaches such as slurry conversion, is how the stable form is reliably reached and confirmed.

Can HTS and manual screening be combined?

Yes. A hybrid strategy can use broad automated coverage where breadth is needed and manual work to confirm, characterize, and follow up on hits. The right balance depends on the compound and the program's objectives.

References

1. Threlfall, T.; Coombes, S. The Ostwald Rule of Stages: Myth or Reality? Cryst. Growth Des. 2022, 22 (5), 3385-3396.

2. Maher, A.; Croker, D. M.; Rasmuson, A. C.; Hodnett, B. K. Solution-Mediated Polymorphic Transformation: Form II to Form III Piracetam in Organic Solvents. Cryst. Growth Des. 2014, 14 (8), 3967-3974.

Authored by the Crystal Pharmatech Solid-State Research and Marketing Teams